Evidence map›Paper›PMID 34824363›Full record

ArticleScientific reports2021

Improved bactericidal efficacy and thermostability of Staphylococcus aureus-specific bacteriophage SA3821 by repeated sodium pyrophosphate challenges.

Hyo Ju Choi, Minsik Kim

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Characterization of a novel phage-plasmid vB_EcoM_ED targeting multidrug-resistant Escherichia coli isolates.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hyo Ju ChoiLaboratory of Molecular Food Microbiology, Department of Food and Nutrition, Brain Korea 21 FOUR, Institute of Symbiotic Life-TECH, College of Human Ecology, Yonsei University, Seoul, 03722, Republic of Korea.
Minsik KimLaboratory of Molecular Food Microbiology, Department of Food and Nutrition, Brain Korea 21 FOUR, Institute of Symbiotic Life-TECH, College of Human Ecology, Yonsei University, Seoul, 03722, Republic of Korea. m.kim@yonsei.ac.kr.
Yonsei University · KR

Funding

Cooperative Research Program for Agriculture Science and Technology Development, Rural Development Administration, Republic of Korea PJ01574702National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) 2019R1C1C1004758Yonsei University Future-leading Research Initiative of 2019 2019-22-0083
6 · The paper itself

Abstract

As antibiotic resistance is being a threat to public health worldwide, bacteriophages are re-highlighted as alternative antimicrobials to fight with pathogens. Various wild-type phages isolated from diverse sources have been tested, but potential mutant phages generated by genome engineering or random mutagenesis are drawing increasing attention. Here, we applied a chelating agent, sodium pyrophosphate, to the staphylococcal temperate Siphoviridae phage SA3821 to introduce random mutations. Through 30 sequential sodium pyrophosphate challenges and random selections, the suspected mutant phage SA3821

Indexed as

DiphosphatesMutagenesisAnti-Bacterial AgentsGenome, ViralHost SpecificityStaphylococcal InfectionsStaphylococcus aureusStaphylococcus PhagesAnti-Bacterial AgentsDiphosphatessodium pyrophosphate

Identifiers

PMID34824363
PMCPMC8616913
OpenAlexW3215201179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.